TY -的T1 -标准胸膜干预措施not high-risk aerosol generating procedures JF - European Respiratory Journal JO - Eur Respir J DO - 10.1183/13993003.01064-2021 VL - 58 IS - 4 SP - 2101064 AU - Arnold, David T. AU - Gregson, Florence K.A. AU - Sheikh, Sadiyah AU - Hamilton, Fergus W. AU - Welch, Hugh AU - Dipper, Alexandra AU - Nava, George W. AU - , AU - Dodd, James W. AU - Clive, Amelia O. AU - Bzdek, Bryan R. AU - Reid, Jonathan P. AU - Maskell, Nick A. Y1 - 2021/10/01 UR - //www.qdcxjkg.com/content/58/4/2101064.abstract N2 - The nosocomial spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has focused attention on the risk of aerosol generating procedures (AGPs) in healthcare [1]. SARS-CoV-2 has been isolated from pleural fluid, which has the potential to infect staff or patients if viraemic fluid is aerosolised during procedures [2, 3]. However, evidence for aerosol generation from pleural procedures is very limited. Current guidelines for appropriate use of personal protective equipment (PPE) while performing pleural procedures are based on expert opinion and application of the precautionary principle [4]. We set out to quantify if pleural procedures generated appreciable aerosol (aerosolised liquid particles that have the potential to carry virus) compared to aerosol sampled during normal respiratory activities of breathing and coughing.Percutaneous pleural procedures should not be considered aerosol generating. This study should inform future iterations of guidelines on the appropriate use of PPE when performing these procedures. https://bit.ly/3xFF71dWe would like to thank all the patients and volunteers who took part in the AERATOR study. ER -